Recombinant influenza vaccines: A supplemental statement of the Canadian Immunization Guide chapter on influenza and statement on seasonal influenza vaccine for 2022–2023

ASEM 文献综述

Official National Advisory Committee on Immunization document (2022) on “Recombinant influenza vaccines: A supplemental statement of the Canadian Immunization Guide chapter on influenza and statement on seasonal influenza vaccine for 2022–2023”. The objective of this statement is to review the available evidence on the efficacy, effectiveness, immunogenicity, and safety of Supemtek, and to provide guidance on its use among adults in Canada.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。